Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of SH-1028 in Locally Advanced or Metastatic NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and efficacy of SH-1028 in locally advanced or metastatic non-small cell lung cancer is ongoing, with the current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• SH-1028 (SH-1028)

Snippet

Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd. | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN